A possible pathogenetic link between absence of first-phase insulin secretion and development of impaired glucose metabolism has been suggested by the results of several cross-sectional studies. Fi rst\x=req-\ phase insulin secretion measured during a + 7 mmol/l hyperglycemic glucose clamp correlated with total glucose disposal during the clamp (r = 0.65, p <0.001, N = 59). To examine whether restoration of first-phase insulin secretion improves peripheral glucose uptake in subjects with impaired glucose utilization, seven insulin-resistant subjects (age 54 (38\p=n-\62) The normal insulin response to intravenous glucose is biphasic, consisting of an initial burst (first-phase) of insulin followed by a slowly increasing phase (secondphase) of insulin secretion (1-3). A lacking first-phase as well as a diminished second-phase insulin secretion is a consistent finding in patients with type 2 diabetes (4, 5).
The normal insulin response to intravenous glucose is biphasic, consisting of an initial burst (first-phase) of insulin followed by a slowly increasing phase (secondphase) of insulin secretion (1) (2) (3) . A lacking first-phase as well as a diminished second-phase insulin secretion is a consistent finding in patients with type 2 diabetes (4, 5) .
The physiological implication of the early peak of insulin secretion on glucose homeostasis is unclear.
Previous cross-sectional studies suggest that the absence of the early peak of insulin secretion is pathogenetically involved in the development of glucose intolerance (3, (5) (6) (7) (8) . Early insulin secretion could act on either the liver or the peripheral muscle tissue, since elevated postpran¬ dial blood glucose could be due to impaired suppression of hepatic glucose output or diminished peripheral glucose uptake. A recent study addressing this question was carried out in healthy insulin-sensitive subjects in whom alterations in insulin secretion were caused by infusion of somatostatin (9) . Absence of first-phase insulin secretion did not affect glucose uptake but led to a delayed suppression of hepatic glucose production. The tives of patients with type 2 diabetes and 10 healthy controls). The subjects came in part from our previous study (7) . From the subjects studied initially, seven insulin-resistant subjects with impaired first-phase and normal second-phase insulin response were selected for further study ( (11) . A computerized open-circuit system was used to measure gas exchange through a transparent plastic canopy (Deltatrac, Datex, Helsinki, Finland).
Protein oxidation was calculated from the urinary urea nitrogen excretion obtained before and during clamping and corrected for changes in urea pool (12 (11.7-16 .2) mmol/1) in the subjects with impaired glucose uptake; this was no different from the controls (12.4 (10.5-13) mmol/1). Second-phase insulin secretion was similar during both experiments and did not differ from the controls (Fig. 2) . Replacement of first-phase insulin secretion did not affect total glucose uptake (20.2 (9.9-23.8) ymol-kg1-min"1). The con¬ tribution of glucose oxidation (8.3 (5.4-11.9) vs 7.6 (6.3-12.6) ¿unol-kg1 -min-1) and non-oxidative glu¬ cose metabolism (9.5 (7.8-14.1) vs 10.7 (2.3-14.4) //mol-kg-1-min1) to total body glucose uptake remained unchanged during both experiments. Suppres¬ sion of hepatic glucose production by insulin was unaffected by the replacement of first-phase insulin secretion (Table 2) . (15) . In the study, the hyperglycémie clamp technique was used to assess insulin secretion and glucose uptake in subjects with mild type 2 diabetes. It was found that six weeks of treatment with glicazide nearly normalized both the first-and second-phase insulin secretion but did not affect glucose uptake in these subjects.
First-phase insulin secretion has also been ascribed a role in the regulation of hepatic glucose output. Absence of first-phase insulin secretion enhanced the stimulatory effect of glucagon on hepatic glucose output in dogs (16, 17) . Accordingly, Luzi and DeFronzo showed that abolishing first-phase insulin secretion by infusion of somatostatin resulted in delayed suppression of hepatic glucose output by insulin (9) . In the present study, replacement of the early insulin secretion did not significantly affect suppression of hepatic glucose production by insulin. The use of somatostatin infusion in the study by Luzi and DeFronzo could at least partially explain the different results, since somatostatin has been shown to influence splanchnic blood flow (10) .
In a recent study Elahi et al. proposed that in healthy subjects regulation of hepatic glucose production by insulin is dependent not just on the ambient insulin concentration but also on the temporal pattern of insulin secretion (18 We conclude that first-phase insulin secretion cor¬ relates with glucose uptake measured during a hyper¬ glycémie clamp. Acute replacement of the early insulin burst does not affect glucose homeostasis in subjects characterized by impaired glucose uptake and normal second-phase insulin secretion. The data suggest that even though present at the same time, impaired glucose uptake and impaired first-phase insulin secretion are separate defects without a causal relationship in these subjects. The effect of first-phase insulin secretion on hepatic glucose production remains to be elucidated.
